Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 4 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymus Neoplasms 1 Thymoma 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Mesothelioma 1 Medulloblastoma 1 Head and Neck Neoplasms 1 Glioma 1 Epilepsy 1 Ependymoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Lobular 1 Bone Neoplasms 1

Interventions

ziprasidone 1 enzalutamide 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Surgical Procedures, Operative 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Registries 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Neuropsychological Tests 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Medical Marijuana 1 Mass Screening 1 Magnetoencephalography 1 Lurasidone Hydrochloride 1 Labetalol 1 Histocompatibility Testing 1 Haloperidol 1 Fosfomycin 1 Clozapine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Epilepsy × Histocompatibility Testing × Clear all

NCT00152659 2023-04-26

Developing Criteria for Cortical Resections

University of Chicago

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡